Literature DB >> 24456109

Validity of the Cantonese Chinese Montreal Cognitive Assessment in Southern Chinese.

Leung-Wing Chu1, Kathy H Y Ng, Andrew C K Law, Antoinette M Lee, Fiona Kwan.   

Abstract

AIM: The objective of the present study was to investigate the reliability and the validity of the Cantonese Chinese Montreal Cognitive Assessment (MoCA) as a brief screening tool of amnestic mild cognitive impairment (aMCI) and Alzheimer's disease (AD) in Southern Chinese older adults.
METHODS: Cognitively normal, aMCI and AD Cantonese-speaking Chinese older adults were recruited from a memory clinic and the community. The English MoCA was translated into Cantonese Chinese and then back-translated. We then evaluated the content validity, reliability, sensitivity and specificity of the Chinese Cantonese MoCA.
RESULTS: We recruited 115 cognitively normal controls, 87 aMCI and 64 AD patients. Only education was positively correlated with the Cantonese MoCA score (r = 0.46, P < 0.001). The Chinese Cantonese MoCA had a high internal consistency with a Cronbach's alpha of 0.85. In the test-retest reliability assessment, the intraclass correlation coefficient (ICC) was 0.95 (P < 0.001). The ICC for the interrater reliability was 0.96 (P < 0.001). Receiving operating characteristic curve analyses showed an area under the curve of 0.85 and 0.99 for aMCI and AD, respectively (both P < 0.001). The optimal cut-off score for detection of aMCI was 22/23, which yielded a sensitivity and specificity of 78% and 73%, respectively. The optimal cut-off score for detection of AD was 19/20, which gave sensitivity and specificity of 94% and 92%, respectively.
CONCLUSION: The Cantonese Chinese MoCA is a consistent and reliable instrument. In terms of its validity, the MoCA is better in the detection of AD than aMCI in Cantonese-speaking Chinese persons. It is only fair for the screening of aMCI.
© 2014 Japan Geriatrics Society.

Entities:  

Keywords:  Cantonese; Chinese; Montreal Cognitive Assessment; mild cognitive impairment; screening; validity

Mesh:

Year:  2014        PMID: 24456109     DOI: 10.1111/ggi.12237

Source DB:  PubMed          Journal:  Geriatr Gerontol Int        ISSN: 1447-0594            Impact factor:   2.730


  15 in total

Review 1.  Translations and cultural adaptations of the Montreal Cognitive Assessment: a systematic and qualitative review.

Authors:  Ilaria Cova; Alessia Nicotra; Giorgia Maestri; Marco Canevelli; Leonardo Pantoni; Simone Pomati
Journal:  Neurol Sci       Date:  2021-11-09       Impact factor: 3.307

Review 2.  Perioperative neurocognitive disorders: A narrative review focusing on diagnosis, prevention, and treatment.

Authors:  Hao Kong; Long-Ming Xu; Dong-Xin Wang
Journal:  CNS Neurosci Ther       Date:  2022-06-01       Impact factor: 7.035

3.  Chinese version of Montreal Cognitive Assessment Basic for discrimination among different severities of Alzheimer's disease.

Authors:  Lin Huang; Ke-Liang Chen; Bi-Ying Lin; Le Tang; Qian-Hua Zhao; Ying-Ru Lv; Qi-Hao Guo
Journal:  Neuropsychiatr Dis Treat       Date:  2018-08-21       Impact factor: 2.570

4.  Three-dimensional pseudocontinuous arterial spin labeling and susceptibility-weighted imaging associated with clinical progression in amnestic mild cognitive impairment and Alzheimer's disease.

Authors:  Qingling Huang; Xuan Cao; Xue Chai; Xiao Wang; Ligang Xu; Chaoyong Xiao
Journal:  Medicine (Baltimore)       Date:  2019-06       Impact factor: 1.817

5.  Cognitive Assessment Tools for Screening Older Adults With Low Levels of Education: A Critical Review.

Authors:  José Wagner Leonel Tavares-Júnior; Ana Célia Caetano de Souza; Gilberto Sousa Alves; Janine de Carvalho Bonfadini; José Ibiapina Siqueira-Neto; Pedro Braga-Neto
Journal:  Front Psychiatry       Date:  2019-12-13       Impact factor: 4.157

6.  Contrastive Analysis of Neuropsychology and Personality Characteristics of Male Lacunar Infarction Patients with Hazardous Drinking and Non-Hazardous Drinking.

Authors:  Jia Yang; Zhandong Qiu; Yu Fang
Journal:  Neuropsychiatr Dis Treat       Date:  2020-11-27       Impact factor: 2.570

7.  Determining Appropriate Screening Tools and Cutoffs for Cognitive Impairment in the Chinese Elderly.

Authors:  Shaowei Zhang; Qi Qiu; Shixing Qian; Xiang Lin; Feng Yan; Lin Sun; Shifu Xiao; Jinghua Wang; Yuan Fang; Xia Li
Journal:  Front Psychiatry       Date:  2021-12-02       Impact factor: 4.157

8.  The Efficacy of Cognitive Training for Elderly Chinese Individuals with Mild Cognitive Impairment.

Authors:  Zhenren Peng; Hu Jiang; Xiaomin Wang; Kaiyong Huang; Yukun Zuo; Xiangmin Wu; Abu S Abdullah; Li Yang
Journal:  Biomed Res Int       Date:  2019-11-30       Impact factor: 3.246

9.  Can RUDAS Be an Alternate Test for Detecting Mild Cognitive Impairment in Older Adults, Thailand?

Authors:  Manchumad Manjavong; Panita Limpawattana; Kittisak Sawanyawisuth
Journal:  Geriatrics (Basel)       Date:  2021-12-16

10.  Neighbourhood physical environment, intrinsic capacity, and 4-year late-life functional ability trajectories of low-income Chinese older population: A longitudinal study with the parallel process of latent growth curve modelling.

Authors:  Shiyu Lu; Yuqi Liu; Yingqi Guo; Hung Chak Ho; Yimeng Song; Wei Cheng; Cheryl Hiu Kwan Chui; On Fung Chan; Chris Webster; Rebecca Lai Har Chiu; Terry Yat Sang Lum
Journal:  EClinicalMedicine       Date:  2021-06-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.